Gestational trophoblastic neoplasia secondary prevention

Gestational trophoblastic neoplasia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gestational trophoblastic neoplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gestational trophoblastic neoplasia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gestational trophoblastic neoplasia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gestational trophoblastic neoplasia secondary prevention
CDC on Gestational trophoblastic neoplasia secondary prevention
Gestational trophoblastic neoplasia secondary prevention in the news
Blogs on Gestational trophoblastic neoplasia secondary prevention
Directions to Hospitals Treating Gestational trophoblastic neoplasia
Risk calculators and risk factors for Gestational trophoblastic neoplasia secondary prevention

Overview

Careful monitoring after the removal of hydatidiform mole or termination of pregnancy can lead to early diagnosis of a choriocarcinoma, which improves outcome.